Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

Point of Care Testing (POCT): defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care.[1][2] This contrasts with the historical pattern in ...

In the United States, the POCT market is valued at USD 2.2 billion in 2025 and projected to reach USD 4.2 billion by 2035, ...

The global sepsis diagnostics market, valued at USD 835.40 million in 2023, is projected to reach USD 1.39 billion by 2029, driven by advancements in healthcare infrastructure and awareness of sepsis, ...

HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation in New Delhi and Mumbai, ...

Plymouth Hospitals NHS Trust is among the first sites in the UK to achieve Clinical Pathology Accreditation (CPA) for Point of Care Testing (POCT). The accreditation covers both connected and ...

A clinical decision tool can reduce antibiotic prescriptions in children with acute illness in primary care without affecting recovery time or follow-up visits compared with usual care.

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...

This webinar's emphasis on CLIA quality standards and the integration of Integri-sense Technology within RAPIDPoint® 500e System seeks to illuminate the path toward enhanced quality management at the ...